Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs

B.A. Tannous, M. Kerami, P.M. van der Stoop, N. Kwiatkowski, J.H. Wang, W.J. Zhou, A.F. Kessler, G. Lewandrowski, L. Hiddingh, N. Sol, T. Lagerweij, L. Wedekind, J.M. Niers, M. Barazas, R.J.A. Nilsson, D. Geerts, P.C. Versélewel de Witt Hamer, C. Hagemann, W.P. Vandertop, O. van Tellingen & 3 others D.P. Noske, N.S. Gray, T. Wurdinger

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1322-1331
JournalJournal of the National Cancer Institute
Volume105
Issue number17
DOIs
Publication statusPublished - 2013

Cite this

Tannous, B.A. ; Kerami, M. ; van der Stoop, P.M. ; Kwiatkowski, N. ; Wang, J.H. ; Zhou, W.J. ; Kessler, A.F. ; Lewandrowski, G. ; Hiddingh, L. ; Sol, N. ; Lagerweij, T. ; Wedekind, L. ; Niers, J.M. ; Barazas, M. ; Nilsson, R.J.A. ; Geerts, D. ; Versélewel de Witt Hamer, P.C. ; Hagemann, C. ; Vandertop, W.P. ; van Tellingen, O. ; Noske, D.P. ; Gray, N.S. ; Wurdinger, T. / Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs. In: Journal of the National Cancer Institute. 2013 ; Vol. 105, No. 17. pp. 1322-1331.
@article{e49d81ac742c44f29adc0b1f567e80e8,
title = "Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs",
author = "B.A. Tannous and M. Kerami and {van der Stoop}, P.M. and N. Kwiatkowski and J.H. Wang and W.J. Zhou and A.F. Kessler and G. Lewandrowski and L. Hiddingh and N. Sol and T. Lagerweij and L. Wedekind and J.M. Niers and M. Barazas and R.J.A. Nilsson and D. Geerts and {Vers{\'e}lewel de Witt Hamer}, P.C. and C. Hagemann and W.P. Vandertop and {van Tellingen}, O. and D.P. Noske and N.S. Gray and T. Wurdinger",
year = "2013",
doi = "10.1093/jnci/djt168",
language = "Undefined/Unknown",
volume = "105",
pages = "1322--1331",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "17",

}

Tannous, BA, Kerami, M, van der Stoop, PM, Kwiatkowski, N, Wang, JH, Zhou, WJ, Kessler, AF, Lewandrowski, G, Hiddingh, L, Sol, N, Lagerweij, T, Wedekind, L, Niers, JM, Barazas, M, Nilsson, RJA, Geerts, D, Versélewel de Witt Hamer, PC, Hagemann, C, Vandertop, WP, van Tellingen, O, Noske, DP, Gray, NS & Wurdinger, T 2013, 'Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs' Journal of the National Cancer Institute, vol. 105, no. 17, pp. 1322-1331. https://doi.org/10.1093/jnci/djt168

Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs. / Tannous, B.A.; Kerami, M.; van der Stoop, P.M.; Kwiatkowski, N.; Wang, J.H.; Zhou, W.J.; Kessler, A.F.; Lewandrowski, G.; Hiddingh, L.; Sol, N.; Lagerweij, T.; Wedekind, L.; Niers, J.M.; Barazas, M.; Nilsson, R.J.A.; Geerts, D.; Versélewel de Witt Hamer, P.C.; Hagemann, C.; Vandertop, W.P.; van Tellingen, O.; Noske, D.P.; Gray, N.S.; Wurdinger, T.

In: Journal of the National Cancer Institute, Vol. 105, No. 17, 2013, p. 1322-1331.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs

AU - Tannous, B.A.

AU - Kerami, M.

AU - van der Stoop, P.M.

AU - Kwiatkowski, N.

AU - Wang, J.H.

AU - Zhou, W.J.

AU - Kessler, A.F.

AU - Lewandrowski, G.

AU - Hiddingh, L.

AU - Sol, N.

AU - Lagerweij, T.

AU - Wedekind, L.

AU - Niers, J.M.

AU - Barazas, M.

AU - Nilsson, R.J.A.

AU - Geerts, D.

AU - Versélewel de Witt Hamer, P.C.

AU - Hagemann, C.

AU - Vandertop, W.P.

AU - van Tellingen, O.

AU - Noske, D.P.

AU - Gray, N.S.

AU - Wurdinger, T.

PY - 2013

Y1 - 2013

U2 - 10.1093/jnci/djt168

DO - 10.1093/jnci/djt168

M3 - Article

VL - 105

SP - 1322

EP - 1331

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 17

ER -